Longport wins first LDS order

Article

Ultrasound developer Longport of Swarthmore, PA, has received its first commercial order for its Longport Digital Scanner (LDS), a portable ultrasound scanner that captures and reproduces images of soft tissue down to 2 cm (SCAN 1/13/99). The

Ultrasound developer Longport of Swarthmore, PA, has received its first commercial order for its Longport Digital Scanner (LDS), a portable ultrasound scanner that captures and reproduces images of soft tissue down to 2 cm (SCAN 1/13/99). The order is for 25 of the systems, and comes from UltraScan East of Allentown, PA.

The order is the latest good news for the company. In April, Longport signed an agreement with Healthlink International of Westerville, OH, in which Healthlink will invest $5 million to support Longport’s R&D efforts (SCAN 5/26/99). The firm then received clearance for LDS from the Food and Drug Administration in June. In September, Longport formed an international subsidiary to begin worldwide marketing of LDS, and applied for listing on the Pacific Stock Exchange.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.